Imaged Capillary Isoelectric Focusing Mass Spectrometer (icIEF-MS) System
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- Not on record
- Points of contact
-
- CDER Acquisition Liaison cderacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring an imaged capillary isoelectric focusing mass spectrometer (icIEF-MS) system, an advanced analytical platform that combines charge-based separation with mass spectrometry for comprehensive characterization of charge variants in biopharmaceutical products including monoclonal antibodies and fusion proteins. The solicitation is estimated to release on January 1, 2027, with award anticipated on September 1, 2027.
The estimated award value ranges from $250,000 to $700,000. Questions and inquiries should be directed to the FDA Acquisition Liaison at cderacquisitions@fda.hhs.gov.
Forecast text
An icIEF-MS system is an advanced hyphenated analytical platform that combines the high-resolution charge-based separation of imaged capillary isoelectric focusing with the structural identification power of mass spectrometry. This instrument enables comprehensive characterization of charge variants in biopharmaceutical products, particularly biologics such as monoclonal antibodies (mAbs) and fusion proteins, providing both quantitative and molecular-level information in a single analytical workflow
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast